Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.

Baricitinib successfully regrew hair in an 8-year-old boy with alopecia totalis linked to a KRT74 gene variant.

Inhibiting TYK2 can restore hair growth in alopecia areata.

Finasteride helps female-pattern hair loss.

Baricitinib is effective in promoting hair growth in severe alopecia areata.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

CDK inhibitors may help treat ARDS and psoriasis but need more testing for safety and effectiveness.

Rapamycin may help treat Leigh syndrome by targeting protein kinase C.

Compounds from Alpinia zerumbet may help with hair regrowth and cancer treatment by targeting PAK1.

BMD-1141 effectively regrows hair in alopecia areata with less frequent dosing than current treatments.

Upadacitinib may effectively treat resistant lichen planopilaris.

Ritlecitinib and baricitinib are effective for alopecia areata, but more research is needed to determine which is better.

Access to JAK inhibitor therapy for alopecia areata patients is difficult, especially for racial minorities.

Tofacitinib helped over half of the patients with severe hair loss regrow at least 50% of their hair.

Tofacitinib may help treat both alopecia areata and inflammatory bowel disease.

Tofacitinib caused significant hair regrowth in adolescents with alopecia universalis who didn't respond to other treatments.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

Rapamycin treatment helps with mitochondrial disease by reducing PKC levels.

Tofacitinib can cause unusual hair growth, requiring careful monitoring and possible laser hair removal.

Oral tofacitinib can treat both psoriasis and alopecia universalis by normalizing inflammatory pathways.

A 50 mg daily dose of ritlecitinib is effective for alopecia areata, with temporary treatment breaks up to 6 weeks not affecting results.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

Short-term treatment with ROCKi increases skin cell growth without changing stem cell features.

Stopping and restarting JAK inhibitors during pregnancy in women with alopecia areata leads to hair loss and regrowth, with most pregnancies resulting in healthy babies.

Switching JAK inhibitors or using dupilumab may help some alopecia areata patients who don't respond well to initial treatments.

Ritlecitinib may be more effective for severe alopecia areata than conventional treatments.

Tofacitinib was found to be a safe and effective treatment for hair regrowth in patients with alopecia areata.

Baricitinib is effective and safe for treating localized vitiligo, alone or with topical tacrolimus.